Inventor · disambiguated record
Matthias Germer
Also filed as: GERMER MATTHIAS
12 granted patents·2 pending applications·23 citations·filing 2008–2021
86Inventor score
Top patents by PatentIndex Score
14 records- 0181US9446146B2Methods and agents for improving targeting of CD138 expressing tumor cellsDAELKEN BENJAMIN·Filed 2008·Granted Sep 20, 2016·10 cites·10 claims
- 0281US9221914B2Agents targeting CD138 and uses thereofKRAUS ELMAR·Filed 2008·Granted Dec 29, 2015·6 cites·10 claims
- 0377US9387261B2Immunoconjugates targeting CD138 and uses thereofKRAUS ELMAR·Filed 2008·Granted Jul 12, 2016·4 cites·18 claims
- 0474US11780909B2Methods of treating viral infections by administering an antibody preparation comprising IGG, IGA and IGMBIOTEST AG·Filed 2021·Granted Oct 10, 2023·0 cites·20 claims
- 0569US9334325B2Method for treating psoriasisOSTERROTH FRANK·Filed 2010·Granted May 10, 2016·2 cites·13 claims
- 0667US10954290B2IgG, IgA and IgM antibody preparations, method of making and method of use in treatmentBIOTEST AG·Filed 2018·Granted Mar 23, 2021·0 cites·17 claims
- 0765US9518110B2Antibody preparationsBIOTEST AG·Filed 2014·Granted Dec 13, 2016·0 cites·26 claims
- 0861US10059759B2Antibody preparationsBIOTEST AG·Filed 2016·Granted Aug 28, 2018·0 cites·15 claims
- 0960US8900806B2Antibody preparationsBIOTEST AG·Filed 2012·Granted Dec 2, 2014·0 cites·23 claims
- 1059US9550831B2Method for treating psoriasisAIGNER SILKE·Filed 2010·Granted Jan 24, 2017·1 cites·13 claims
- 1143US2017081418A1Immunoconjugates targeting cd138 and uses thereofBIOTEST AG·Filed 2016·Application pending·0 cites
- 1241US2016185854A1Agents targeting cd138 and uses thereofBIOTEST AG·Filed 2015·Application pending·0 cites
- 1330US9512226B2Agent for treating diseaseGERMER MATTHIAS·Filed 2010·Granted Dec 6, 2016·0 cites·34 claims
- 1428US10322169B2Process for preparing a powder comprising a human coagulation factor protein and a lactic acid polymerEVONIK ROEHM GMBH·Filed 2016·Granted Jun 18, 2019·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →